Evolv Technologies Holdings, Inc.
For the period ended Dec 31, 2024. Filed Apr 28, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Apr 28, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits and Financial Statement Schedules
(a)(1) Financial Statements.
See "Index to Consolidated Financial Statements" included in Item 8, Financial Statements and Supplementary Data of this Annual Report on Form 10-K.
(a)(2) Financial Statement Schedules.
All financial statement schedules for the Company have been included in the consolidated financial statements or the related footnotes, or are either inapplicable or not required.
(a)(3) Exhibits.
The following is a list of exhibits filed or incorporated by reference as part of this Annual Report on Form 10-K.
EXHIBIT INDEX
| Incorporated by Reference | |||||
|---|---|---|---|---|---|
| ExhibitNo. · Description · Form · File Number · Exhibit · Filing Date · Filed/FurnishedHerewith | |||||
| 2.1 | Agreement and Plan of Merger dated as of March 5, 2021, by and among NewHold Investment Corp., NHIC Sub Inc. and Evolv Technologies, Inc. | Form 8-K | 001-39417 | 2.1 | March 8, 2021 |
| 2.2 | First Amendment to Agreement and Plan of Merger dated June 5, 2021, by and among NewHold Investment Corp., NHIC Sub Inc. and Evolv Technologies, Inc. | Form 8-K | 001-39417 | 2.2 | July 22, 2021 |
| 3.1 | Second Amended and Restated Certificate of Incorporation. | Form 10-Q | 001-39417 | 3.1 | November 15, 2021 |
| 3.2 | Amended and Restated Bylaws. | Form 8-K | 001-39417 | 3.1 | January 31, 2024 |
| 4.1 | Specimen Warrant Certificate of the Registrant | Form S-1/A | 333-233299 | 4.3 | July 27, 2020 |
| 4.2 | Warrant Agreement, dated July 30, 2020, by and between Continental Stock Transfer & Trust Company and NewHold Investment Corp. | Form S-1/A | 333-233299 | 4.4 | July 27, 2020 |
| 10.1 | Letter Agreement, dated March 5, 2021, by and among NewHold Industrial Technology Holdings LLC, Evolv Technologies, Inc., NewHold Investment Corp. and certain other parties thereto. | Form 8-K | 001-39417 | 10.2 | March 8, 2021 |
| 10.2 | Stockholder Agreement dated as of March 5, 2021 by and between NewHold Investment Corp. and Motorola Solutions, Inc. | Form 8-K | 001-39417 | 10.4 | March 8, 2021 |
| 10.3# | Form of Indemnification Agreement. | Form S-4/A | 333-255017 | 10.10 | June 9, 2021 |
| 10.4# | Offer Letter between Evolv Technologies Holdings, Inc. and John Kedzierski | Form S-4/A | 333-255017 | 10.1 | December 9, 2024 | |
| 10.5# | Executive Employment Agreement between Evolv Technologies, Inc. and Anil R. Chitkara. | Form S-4/A | 333-255017 | 10.12 | June 9, 2021 | |
| 10.6# | Evolv Technologies Holdings, Inc. 2021 Incentive Award Plan. | Form S-8 | 333-259961 | 99.1 | September 21, 2021 | |
| 10.7# | Evolv Technologies Holdings, Inc. 2021 Employee Stock Purchase Plan. | Form S-8 | 333-259961 | 99.2 | September 21, 2021 | |
| 10.8# | Amended and Restated Registration Rights Agreement by and among NewHold, Evolv and certain stockholders. | Form 10-K | 001-39417 | 10.9 | March 24, 2023 | |
| 10.9# | Form of Restricted Stock Unit Award Agreement under the 2021 Incentive Award Plan | Form 10-Q | 001-39417 | 10.1 | November 15, 2021 | |
| 10.10# | Form of Option Award Agreement under the 2021 Incentive Award Plan | Form 10-Q | 001-39417 | 10.1 | November 9, 2022 | |
| 10.11# | Evolv Technologies, Inc. 2013 Employee, Director and Consultant Equity Incentive Plan. | Form S-8 | 333-259961 | 99.3 | September 21, 2021 | |
| 10.12# | Evolv Technologies Holdings, Inc. Executive Officer Performance Bonus Plan | Form 8-K | 001-39417 | 10.1 | March 2, 2023 | |
| 10.13# | Evolv Technologies Holdings, Inc. Severance and Change in Control Plan | Form 8-K | 001-39417 | 10.1 | October 31, 2022 | |
| 10.14# | Amended Non-Employee Director Compensation Policy | Form 10-Q | 001-39417 | 10.1 | November 9, 2023 | |
| 19.1 | Insider Trading Compliance Policy | * | ||||
| 21.1 | List of Subsidiaries. | * | ||||
| 23.1 | Consent of PricewaterhouseCoopers LLP. | * | ||||
| 31.1 | Certification of Principal Executive Officer pursuant to Exchange Act Rule 13a-14(a). | * | ||||
| 31.2 | Certification of Principal Financial Officer pursuant to Exchange Act Rule 13a-14(a). | * | ||||
| 32.1 | Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350. | ** | ||||
| 32.2 | Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350. | ** | ||||
| 97# | Executive Officer Compensation Recovery Policy | * | ||||
| 101.INS | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | * | ||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | * | ||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document. | * |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. | * |
| 101.LAB | Inline XBRL Taxonomy Extension Labels Linkbase Document. | * |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | * |
| 104 | Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101) | * |
- Filed herewith.
** Furnished herewith.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.